Ascend Wellness Holdings Files 8-K on Financials
Ticker: AAWH · Form: 8-K · Filed: Mar 12, 2024 · CIK: 1756390
| Field | Detail |
|---|---|
| Company | Ascend Wellness Holdings, Inc. (AAWH) |
| Form Type | 8-K |
| Filed Date | Mar 12, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k
Related Tickers: AAWH
TL;DR
AAWH filed an 8-K on March 12th detailing financial results.
AI Summary
Ascend Wellness Holdings, Inc. filed an 8-K on March 12, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance.
Why It Matters
This filing provides investors with crucial updates on Ascend Wellness Holdings' financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing of financial results and does not indicate any immediate or significant new risks.
Key Players & Entities
- Ascend Wellness Holdings, Inc. (company) — Registrant
- March 12, 2024 (date) — Date of Report
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filed?
This 8-K was filed on March 12, 2024.
What is the exact name of the company filing this report?
The exact name of the registrant is Ascend Wellness Holdings, Inc.
What is the principal executive office address for Ascend Wellness Holdings, Inc.?
The principal executive offices are located at 1411 Broadway, 16th Floor, New York, NY 10018.
What is the SIC code for Ascend Wellness Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Ascend Wellness Holdings, Inc. is 2833, which corresponds to MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.
Filing Stats: 485 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2024-03-12 07:40:22
Filing Documents
- aawh-20240312.htm (8-K) — 22KB
- ex991awhq42023pressrelease.htm (EX-99.1) — 214KB
- awhlogo.jpg (GRAPHIC) — 492KB
- 0001628280-24-010368.txt ( ) — 1036KB
- aawh-20240312.xsd (EX-101.SCH) — 2KB
- aawh-20240312_lab.xml (EX-101.LAB) — 20KB
- aawh-20240312_pre.xml (EX-101.PRE) — 12KB
- aawh-20240312_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On March 12, 2024, Ascend Wellness Holdings, Inc. (the "Company") issued a press release announcing financial results for the quarter and year ended December 31, 2023. A copy of the press release is being furnished as Exhibit 99.1 to this Form 8-K, which is incorporated into this item by reference. The information furnished under this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Exhibit Description 99.1 Press release dated March 12, 2024 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Ascend Wellness Holdings, Inc. March 12, 2024 /s/ Mark Cassebaum Mark Cassebaum Chief Financial Officer (Principal Financial Officer) 2